Liraglutide Indicated to Reduce Risk for Cardiovascular Events (FREE)

By Kelly Young Edited by Susan Sadoughi, MD, and Andr é Sofair, MD, MPH The type 2 diabetes drug liraglutide (Victoza) has received a new indication, …
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news